Filter
3288
Filtered Results: 3288
Text search:
TB
drugs
Featured
Recommendations
279
New Publications
956
Language
Document type
No document type
2229
Studies & Reports
366
Guidelines
328
Manuals
107
Strategic & Response Plan
90
Fact sheets
51
Situation Updates
47
Training Material
42
Infographics
15
Resource Platforms
6
Brochures
3
Online Courses
3
Videos
1
Countries / Regions
India
196
Kenya
121
South Africa
112
Western and Central Europe
89
Ethiopia
80
Global
79
Uganda
78
Tanzania
76
Zambia
72
Nepal
67
Malawi
62
Nigeria
61
Eastern Europe
58
Sierra Leone
55
Liberia
51
Rwanda
48
Namibia
47
Ghana
46
Africa
45
Ukraine
42
Myanmar / Burma
41
Bangladesh
40
Lesotho
38
Latin America and the Carribbean
34
Philippines
33
Cambodia
33
Asia
31
Indonesia
31
Zimbabwe
29
Botswana
24
South–East Asia Region
23
Senegal
20
Russia
20
Colombia
17
Mozambique
17
Congo, Democratic Republic of
14
Eswatini/ Swaziland
14
Peru
13
Burkina Faso
12
Germany
12
Argentina
12
Pakistan
12
Haiti
11
East and Southern Africa
10
Tajikistan
9
Benin
9
Albania
9
Brazil
9
South Sudan
9
Armenia
8
Venezuela
8
Syria
7
West and Central Africa
7
Georgia
7
El Salvador
6
Cameroon
6
Paraguay
6
Vietnam
6
Thailand
5
Laos
5
Guinea
5
Middle East and North Africa
5
Bolivia
5
Moldova
5
Sudan
5
Afghanistan
4
Eastern Europe and Central Asia
4
Southern Africa
4
Madagascar
4
North Macedonia
3
Timor Leste/ East Timor
3
Iran
3
Estonia
3
USA
3
Jordan
3
Western Pacific Region
3
Uruguay
3
Lebanon
3
Sri Lanka
3
Bhutan
3
Iraq
3
Somalia
3
Ecuador
3
Burundi
2
Morocco
2
Saudi Arabia
2
North America
2
Papua New Guinea
2
Yemen
2
Romania
2
Poland
2
Angola
2
North Korea
1
Switzerland
1
Mexico
1
Gambia
1
Chile
1
Singapore
1
Niger
1
Mongolia
1
Qatar
1
Bulgaria
1
Guinea-Bissau
1
Hungary
1
Ireland
1
Gabon
1
Turkmenistan
1
Belgium
1
Maldives
1
Tunisia
1
Spain
1
Belarus
1
Nicaragua
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Central African Republic
1
Honduras
1
Mali
1
Libya
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1503
Clinical Guidelines
242
Public Health
99
Women & Child Health
84
Key Resources
64
Capacity Building
41
Pharmacy & Technologies
31
Annual Report MEDBOX
2
Toolboxes
TB
750
HIV
490
AMR
132
COVID-19
81
Mental Health
70
NTDs
70
Pharmacy
66
Caregiver
55
Refugee
41
Health Financing Toolbox
36
Ebola & Marburg
33
NCDs
33
Global Health Education
29
Conflict
27
Polio
23
Rapid Response
20
Disability
19
Natural Hazards
13
Planetary Health
10
Social Ethics
6
Specific Hazards
4
Malaria
3
Cholera
2
South Sudan
1
Zika
1
Background: Community health worker (CHW) programmes are a valuable component of primary care in resource-poor settings. The evidence supporting their effectiveness generally shows improvements in disease-specific outcomes relative to the absence of a CHW programme. In this study, we evaluated expan...
This report has been developed, based on data provided by the TB & ORD surveillance system from across Rwanda. It provides a comprehensive picture of the occurrence and management of TB & ORD and Leprosy in Rwanda. It is structured based on the 2013-2018 Rwanda TB national strategic plan (2013-2018 ...
2nd edition.
Like the original, this second edition of the guidance aims to inform the revision of existing national guidelines and standards for managing Tuberculosis (TB), many of which include guidance on children. It includes recommendations, based on the best available evidence, for improving ...
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
This regional advocacy strategy on HIV and AIDS, tuberculosis (TB) and sexually transmitted infetions (STIs) is intended for use by Southern African Development Community (SADC) Member States at a national level. This is an overall advocacy strategy highlighting the most important issues relating to...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
The guide is suitable and can be used for the following audiences:
1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice;
2. governmental and non-governmental employers of lay and professional TB treatment ...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Version 1.0, 2014-11-21
Introduction:
This document lists TB indicators that can be derived from the recording and reporting tools defined
in Definitions and reporting framework for tuberculosis – 2013 revision (WHO/HTM/TB/2013.2).
Geneva, World Health Organization; 2013. (http://www.who.int/t...
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The Infection Prevention and Control (IPC) Legal Framework comes before the Specialized Technical Committee on Health and Drug Control for adoption and endorsement. The IPC Legal Framework is designed to guide Member States in the review and strengthening of laws and policies that support IPC at bot...
The Creditor Reporting System was analysed for official development assistance funding disbursements towards TB control in 11 conflict-affectedstates, 17 non-conflict-affected fragile states and 38 comparable non-fragile states. The amounts of funding, funding relative to burden, funding relative to...
The guidelines acknowledge that overcrowding, unhygienic conditions and high inmate turn over contribute to the spread of infectious diseases within correctional facilities. The document states that voluntary HIV counselling and testing must be offered to all inmates when they enter facilities, duri...
This handbook builds on lessons learned from surveys implemented 2015-2017 and advice provided by the Global task force on TB patient cost surveys. It provides a standardized methodology for conducting health facility-based cross-sectional surveys to assess the direct and indirect costs incurred by ...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Zambia has recognised the Public Health threat of antimicrobial resistance and its impact on morbidity and mortality, as well as the subsequent economic consequences. The country has recorded microorganisms which have developed resistance to antimicrobial drugs. Notable among these are; Multidrug Re...
Protocol for the management of specialized centres for the treatment of people with alcohol and other drug abuse problems (CETAD) in the framework of the COVID-19 pandemic. Version 1.
